Carboxyl Tail Cysteine Mutants of the Thyrotropin-Releasing Hormone Receptor Type 1 Exhibit Constitutive Signaling: Role of Palmitoylation

We studied the role of carboxyl tail cysteine residues and their palmitoylation in constitutive signaling by the thyrotropin-releasing hormone (TRH) receptor type 1 (TRH-R1) in transfected mammalian cells and in Xenopus laevis oocytes. To study palmitoylation, we inserted a factor Xa cleavage site within the third extracellular loop of TRH-R1, added a carboxyl-terminal C9 immunotag and expressed the mutant receptor in Chinese hamster ovary cells. We identified TRH-R1-specific palmitoylation in the transmembrane helix-7/carboxyl-tail receptor fragment mainly at Cys-335 and Cys-337. In contrast to a mutant truncated at Cys-335 that was reported previously to be constitutively active, a receptor truncated at Lys-338 (K338Stop), which preserves Cys-335 and Cys-337, and C337Stop and N336Stop, which preserve Cys-335, did not exhibit increased constitutive signaling. TRH-R1 mutants substituted singly by Gly or Ser at Cys-335 or Cys-337 did not exhibit constitutive signaling. By contrast, substitution of both cysteines (C335G/C337G or C335S/C337S) yielded TRH-R1 mutants that exhibited marked constitutive signaling in mammalian cells. In the oocyte, constitutive signaling by C335G/C337G resulted in homologous (of C335G/C337G) and heterologous (of M1 muscarinic receptor) desensitization. Because both Cys-335 and Cys-337 have to be substituted or deleted for constitutive signaling, we propose that a single palmitoylation site in the proximal carboxyl tail is sufficient to constrain TRH-R1 in an inactive conformation.

[1]  R. Osman,et al.  Agonist-induced conformational changes in thyrotropin-releasing hormone receptor type I: disulfide cross-linking and molecular modeling approaches. , 2005, Biochemistry.

[2]  J. Smotrys,et al.  Palmitoylation of intracellular signaling proteins: regulation and function. , 2004, Annual review of biochemistry.

[3]  A. Navratil,et al.  Residues in the hydrophilic face of putative helix 8 of oxytocin receptor are important for receptor function. , 2004, Biochemistry.

[4]  P. Lehenkari,et al.  Functional diversity of endothelin pathways in human lung fibroblasts may be based on structural diversity of the endothelin receptors. , 2003, Biochemistry.

[5]  M. Bouvier,et al.  Role of palmitoylation/depalmitoylation reactions in G-protein-coupled receptor function. , 2003, Pharmacology & therapeutics.

[6]  M. Gershengorn,et al.  Correlation between basal signaling and internalization of thyrotropin-releasing hormone receptors: evidence for involvement of similar receptor conformations. , 2002, Endocrinology.

[7]  T. Sakmar,et al.  Evidence that helix 8 of rhodopsin acts as a membrane-dependent conformational switch. , 2002, Biochemistry.

[8]  D. Richter,et al.  The 5-Hydroxytryptamine(4a) Receptor Is Palmitoylated at Two Different Sites, and Acylation Is Critically Involved in Regulation of Receptor Constitutive Activity* , 2002, The Journal of Biological Chemistry.

[9]  K. Palczewski,et al.  Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.

[10]  K. Palczewski,et al.  Crystal structure of rhodopsin: implications for vision and beyond. , 2001, Current opinion in structural biology.

[11]  Y. Oron,et al.  Constitutive Signaling by Kaposi's Sarcoma-associated Herpesvirus G-protein-coupled Receptor Desensitizes Calcium Mobilization by Other Receptors* , 2001, The Journal of Biological Chemistry.

[12]  R. Osman,et al.  Minireview: Insights into G protein-coupled receptor function using molecular models. , 2001, Endocrinology.

[13]  W. Müller-Esterl,et al.  Correlations in Palmitoylation and Multiple Phosphorylation of Rat Bradykinin B2 Receptor in Chinese Hamster Ovary Cells* , 1999, The Journal of Biological Chemistry.

[14]  Y. Oron,et al.  Inverse agonist abolishes desensitization of a constitutively active mutant of thyrotropin‐releasing hormone receptor: role of cellular calcium and protein kinase C , 1999, British journal of pharmacology.

[15]  M. Hayashi,et al.  Palmitoylation of muscarinic acetylcholine receptor m2 subtypes: reduction in their ability to activate G proteins by mutation of a putative palmitoylation site, cysteine 457, in the carboxyl-terminal tail. , 1997, Archives of biochemistry and biophysics.

[16]  R. Osman,et al.  Molecular and cellular biology of thyrotropin-releasing hormone receptors. , 1996, Physiological reviews.

[17]  Y. Oron,et al.  A constitutively active mutant thyrotropin-releasing hormone receptor is chronically down-regulated in pituitary cells: evidence using chlordiazepoxide as a negative antagonist. , 1995, Molecular endocrinology.

[18]  B. Mouillac,et al.  Palmitoylation of G-protein-coupled receptors: a dynamic modification with functional consequences. , 1995, Biochemical Society transactions.

[19]  Y. Oron,et al.  Truncation of the Thyrotropin-releasing Hormone Receptor Carboxyl Tail Causes Constitutive Activity and Leads to Impaired Responsiveness in Xenopus Oocytes and AtT20 Cells (*) , 1995, The Journal of Biological Chemistry.

[20]  L. Limbird,et al.  Mutations of the alpha 2A-adrenergic receptor that eliminate detectable palmitoylation do not perturb receptor-G-protein coupling. , 1993, The Journal of biological chemistry.

[21]  E. Geras-Raaka,et al.  Regulation by thyrotropin-releasing hormone (TRH) of TRH receptor mRNA degradation in rat pituitary GH3 cells. , 1992, The Journal of biological chemistry.

[22]  R. Crouch,et al.  Palmitylation of a G-protein coupled receptor. Direct analysis by tandem mass spectrometry. , 1992, The Journal of biological chemistry.

[23]  R. Straub,et al.  Xenopus laevis oocytes injected with mammalian pituitary mRNA as a model system for study of thyrotropin-releasing hormone action. , 1990, The Journal of experimental zoology. Supplement : published under auspices of the American Society of Zoologists and the Division of Comparative Physiology and Biochemistry.

[24]  M. Caron,et al.  Palmitoylation of the human beta 2-adrenergic receptor. Mutation of Cys341 in the carboxyl tail leads to an uncoupled nonpalmitoylated form of the receptor. , 1989, The Journal of biological chemistry.

[25]  A. H. Drummond,et al.  The interaction of benzodiazepines with thyrotropin‐releasing hormone receptors on clonal pituitary cells , 1989, British journal of pharmacology.

[26]  A. S. Bogachuk,et al.  Two adjacent cysteine residues in the C‐terminal cytoplasmic fragment of bovine rhodopsin are palmitylated , 1988, FEBS letters.

[27]  R. Straub,et al.  Mechanism of membrane electrical response to thyrotropin-releasing hormone in Xenopus oocytes injected with GH3 pituitary cell messenger ribonucleic acid. , 1987, Molecular endocrinology.

[28]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .